Institutional investors purchased a net $773.2 thousand shares of PBYI during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 94.31% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 1.0 Million shares of Puma Biotechnology Inc